Mimedx Group Files 8-K
Ticker: MDXG · Form: 8-K · Filed: Nov 18, 2024 · CIK: 1376339
| Field | Detail |
|---|---|
| Company | Mimedx Group, Inc. (MDXG) |
| Form Type | 8-K |
| Filed Date | Nov 18, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, 8-k, disclosure
TL;DR
MIMEDX filed a routine 8-K, no major news.
AI Summary
Mimedx Group, Inc. filed an 8-K on November 18, 2024, to report on a Regulation FD Disclosure and to file Financial Statements and Exhibits. The filing does not contain specific financial figures or new material events beyond the standard reporting requirements.
Why It Matters
This filing indicates Mimedx Group is fulfilling its regulatory reporting obligations with the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — This is a routine SEC filing for disclosure and exhibits, not indicating any new material risks or events.
Key Players & Entities
- MIMEDX GROUP, INC. (company) — Registrant
- November 18, 2024 (date) — Date of Report
FAQ
What is the purpose of this 8-K filing?
The purpose of this 8-K filing is to provide a Regulation FD Disclosure and to file Financial Statements and Exhibits.
What is the exact name of the registrant?
The exact name of the registrant is MIMEDX GROUP, INC.
On what date was this report filed?
The report was filed on November 18, 2024.
What is the company's principal executive office address?
The address of the principal executive offices is 1775 West Oak Commons Ct., NE, Marietta GA 30062.
What is the company's telephone number?
The company's telephone number, including area code, is (770) 651-9100.
Filing Stats: 865 words · 3 min read · ~3 pages · Grade level 14.3 · Accepted 2024-11-18 08:55:32
Key Financial Figures
- $0.001 — nge on which registered Common Stock, $0.001 par value per share MDXG The Nasdaq
Filing Documents
- d808931d8k.htm (8-K) — 27KB
- d808931dex991.htm (EX-99.1) — 21KB
- g808931ex99_1s10g1.jpg (GRAPHIC) — 84KB
- g808931ex99_1s11g1.jpg (GRAPHIC) — 97KB
- g808931ex99_1s12g1.jpg (GRAPHIC) — 95KB
- g808931ex99_1s13g1.jpg (GRAPHIC) — 120KB
- g808931ex99_1s14g1.jpg (GRAPHIC) — 82KB
- g808931ex99_1s15g1.jpg (GRAPHIC) — 66KB
- g808931ex99_1s16g1.jpg (GRAPHIC) — 79KB
- g808931ex99_1s17g1.jpg (GRAPHIC) — 98KB
- g808931ex99_1s18g1.jpg (GRAPHIC) — 83KB
- g808931ex99_1s1g1.jpg (GRAPHIC) — 71KB
- g808931ex99_1s2g1.jpg (GRAPHIC) — 112KB
- g808931ex99_1s3g1.jpg (GRAPHIC) — 131KB
- g808931ex99_1s4g1.jpg (GRAPHIC) — 105KB
- g808931ex99_1s5g1.jpg (GRAPHIC) — 124KB
- g808931ex99_1s6g1.jpg (GRAPHIC) — 133KB
- g808931ex99_1s7g1.jpg (GRAPHIC) — 115KB
- g808931ex99_1s8g1.jpg (GRAPHIC) — 120KB
- g808931ex99_1s9g1.jpg (GRAPHIC) — 92KB
- 0001193125-24-260490.txt ( ) — 2669KB
- mdxg-20241118.xsd (EX-101.SCH) — 3KB
- mdxg-20241118_lab.xml (EX-101.LAB) — 18KB
- mdxg-20241118_pre.xml (EX-101.PRE) — 11KB
- d808931d8k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Exchange Act, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIMEDX GROUP, INC. November 18, 2024 By: /s/ Doug Rice Doug Rice Chief Financial Officer